Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$4.1B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital healthcare solutions, particularly in cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

$-0.00

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital healthcare solutions, particularly in cardiac monitoring. With a market cap of $4 billion, it plays a crucial role in the growing health tech sector, leveraging technology to improve patient care and streamline diagnostic processes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1-2026, iRhythm reported an EPS of $-0.35, outperforming estimates by 37.83%. The stock reacted positively, gaining 6.96% the following day.

Management Promises & Guidance

Continued focus on expanding market reach.
Enhancements in product offerings to improve patient outcomes.
Commitment to cost management and operational efficiency.

Expectations

Wall Street Expectations

Analysts expect iRhythm to report a break-even EPS and revenue around $219 million. The market is closely watching for any signs of growth or operational improvements.

Bull Case

If iRhythm beats expectations, it could signal strong demand for its cardiac monitoring solutions and effective cost management, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows continued losses, it may raise concerns about its growth trajectory and market position.

Key Metrics to Watch

EPS

$-0.00

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

Revenue

$219M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will iRhythm achieve revenue of at least $219 million this quarter?

This figure is critical as it reflects the company's ability to meet market demand and grow its sales.

Can iRhythm narrow its EPS loss to $-0.00 or better?

A smaller loss or break-even EPS would indicate improved operational efficiency and could boost investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate iRhythm's potential for revenue growth due to recent product innovations and market expansion efforts.

Supporting Evidence

The company has a history of beating EPS estimates, suggesting operational improvements.

Recent trends in healthcare technology indicate increasing demand for remote monitoring solutions.

Options pricing suggests higher volatility, indicating that traders expect significant news or changes.

Key Risk

If revenue exceeds $222 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating iRhythm's ability to improve profitability and sustain revenue growth in a competitive healthcare landscape.

Bull Confirmed If

Achieving revenue of $219 million or higher with an EPS loss of $-0.00 or better would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.10 alongside revenue below $218 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a move of about 3.3%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could rise by about 1.17% on the first trading day post-earnings.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may see muted movement.

Miss

If the company misses estimates, the stock could experience a slight decline, as seen with an average reaction of 0.00% when they miss.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on sales.
2Any commentary on partnerships or collaborations that could enhance market reach.
3Insights into cost management strategies and their effect on profitability.
4Feedback on customer adoption rates for existing products.
5Management's outlook on future market trends and competitive landscape.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital healthcare solutions, particularly in cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

$-0.00

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1-2026, iRhythm reported an EPS of $-0.35, outperforming estimates by 37.83%. The stock reacted positively, gaining 6.96% the following day.

Management Promises & Guidance

Continued focus on expanding market reach.
Enhancements in product offerings to improve patient outcomes.
Commitment to cost management and operational efficiency.

Expectations

Wall Street Expectations

Analysts expect iRhythm to report a break-even EPS and revenue around $219 million. The market is closely watching for any signs of growth or operational improvements.

Bull Case

If iRhythm beats expectations, it could signal strong demand for its cardiac monitoring solutions and effective cost management, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet revenue expectations or shows continued losses, it may raise concerns about its growth trajectory and market position.

Key Metrics to Watch

EPS

$-0.00

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

Revenue

$219M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will iRhythm achieve revenue of at least $219 million this quarter?

This figure is critical as it reflects the company's ability to meet market demand and grow its sales.

Can iRhythm narrow its EPS loss to $-0.00 or better?

A smaller loss or break-even EPS would indicate improved operational efficiency and could boost investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate iRhythm's potential for revenue growth due to recent product innovations and market expansion efforts.

Supporting Evidence

The company has a history of beating EPS estimates, suggesting operational improvements.

Recent trends in healthcare technology indicate increasing demand for remote monitoring solutions.

Options pricing suggests higher volatility, indicating that traders expect significant news or changes.

Key Risk

If revenue exceeds $222 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating iRhythm's ability to improve profitability and sustain revenue growth in a competitive healthcare landscape.

Bull Confirmed If

Achieving revenue of $219 million or higher with an EPS loss of $-0.00 or better would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.10 alongside revenue below $218 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a move of about 3.3%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could rise by about 1.17% on the first trading day post-earnings.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may see muted movement.

Miss

If the company misses estimates, the stock could experience a slight decline, as seen with an average reaction of 0.00% when they miss.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on sales.
2Any commentary on partnerships or collaborations that could enhance market reach.
3Insights into cost management strategies and their effect on profitability.
4Feedback on customer adoption rates for existing products.
5Management's outlook on future market trends and competitive landscape.